Federal Circuit Affirms Dismissal Of Patent Dispute Over Cholesterol Drug

WASHINGTON, D.C. A Delaware federal judge did not err in dismissing patent infringement claims levied against a series of generic drug manufacturers, the Federal Circuit U.S. Court of Appeals held Feb. 9 (AstraZeneca Pharmaceuticals LP v. Apotex Inc., et al., Nos. 2011-1182, -1183, -1184, -1185, -1186, -1187, -1188, -1189, -1190, Fed. Cir.; 2012 U.S. App. LEXIS 2512). Full story on lexis.com